Visual effects firm says that Disney contracted with people who stole the technologyThe company was slapped with a lawsuit on Monday by a visual effects company, which claims that its technology was misappropriated for “Beauty and the Beast,” “Guardians of the Galaxy” and Avengers:“[I]n all of the film industry and media accolades about the record-breaking success of ‘Beauty and the Beast,’ and the acclaimed cutting-edge digital MOVA Contour technology that made the film’s success possible, nowhere is it mentioned that the patented and copyright-protected MOVA Contour technology was stolen from its inventor and developer, Rearden LLC, and its owner Rearden Mova LLC,” the suit reads.Nowhere is it mentioned that although Disney had previously contracted with Rearden LLC and its controlled entities on four previous major motion pictures to use MOVA Contour and knew of a Rearden Demand Letter to one of the thieves demanding immediate return of the stolen MOVA Contour system, Disney nonetheless contracted with the thieves to use the stolen MOVA Contour system.
NYS Entity Status
NYS Filing Date
MAY 23, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - FAB VISUALS LLC
AROUND THE WEB
- Disney Slapped With Lawsuit Over ‘Guardians of the Galaxy,’ ‘Avengers: Age of Ultron’ Effects
By Tim Kenneally, provided by
- Monday Jul 17, 2017
- Shadow of the Colossus is back
By Jeff Grubb - Monday Jun 12, 2017
Sony revealed that it is bringing Shadow of the Colossus to the PlayStation 4. The publisher showed off Shadow of the Colossus for PlayStation 4. This is a remaster that takes the same giant beasts and action from the PlayStation 2 original and updates it with modern visuals. It is due out in 2018 for […]
- How to Get to New York During Penn Station’s Summer Repairs
By TOM WRIGHT-PIERSANTI - Thursday Jul 6, 2017
Starting July 10, repairs at Penn Station will disrupt the daily commute for thousands of Long Island Rail Road and New Jersey Transit riders. Here is a guide to help navigate the rails this summer.
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.